Mitofusin 2 (MFN2) is a dynamin-related GTPase localized to the outer mitochondrial membrane that functions as a critical regulator of mitochondrial dynamics and inter-organellar communication. The protein is encoded by the MFN2 gene on human chromosome 1 and exists as a ~86 kDa transmembrane GTPase essential for cellular energy homeostasis and neuronal function. MFN2 was initially identified as a component of the mitochondrial fusion machinery alongside its paralog Mitofusin 1 (MFN1) and the inner-membrane protein OPA1. Beyond its canonical role in mitochondrial morphology, MFN2 has emerged as a crucial mediator of mitochondria-endoplasmic reticulum (ER) tethering, regulating calcium transfer and metabolic coordination between these organelles. Loss-of-function mutations in MFN2 cause Charcot-Marie-Tooth disease type 2A (CMT2A), a peripheral neuropathy characterized by progressive axonal degeneration, establishing its importance for neuronal maintenance and survival.
Function/Biology
MFN2 is a GTPase that catalyzes the fusion of mitochondrial outer membranes through a complex mechanism involving GTP hydrolysis-dependent conformational changes. The protein contains two transmembrane domains embedded in the outer mitochondrial membrane, with its GTPase domain positioned in the cytoplasm. MFN2 functions through the formation of trans-oligomeric assemblies between opposing mitochondrial membranes, where anti-parallel GTPase domains interact and pull membranes into close proximity to facilitate fusion. This process requires GTP binding to stabilize active conformations and subsequent hydrolysis to drive the fusion reaction forward.
Beyond mitochondrial fusion, MFN2 serves as a critical organellar tether between mitochondria and the endoplasmic reticulum. The protein directly interacts with PACS2 and other ER-resident proteins to create stable contact sites termed mitochondria-associated membranes (MAMs). These specialized regions enable the transfer of lipids from ER to mitochondria and regulate calcium signaling from ER stores to mitochondrial calcium uptake machinery. This bidirectional communication is essential for maintaining cellular bioenergetics and calcium homeostasis.
MFN2 activity is tightly regulated through post-translational modifications. Phosphorylation by kinases such as PINK1 modulates its fusion capacity, while ubiquitination by E3 ligases like Parkin marks damaged MFN2 for proteasomal degradation, linking mitochondrial quality control to dynamic remodeling.
Role in Neurodegeneration
MFN2 dysfunction is implicated in multiple neurodegenerative conditions, where impaired mitochondrial dynamics and ER-mitochondrial communication compromise neuronal survival. In Alzheimer's disease, reduced MFN2 expression and activity correlate with accumulation of dysfunctional mitochondria and disrupted calcium homeostasis, contributing to amyloid-beta-induced toxicity and tau pathology. Parkinson's disease involves compromised MFN2-mediated mitochondrial quality control, allowing damaged mitochondria to persist and generate excessive reactive oxygen species that promote alpha-synuclein aggregation.
The peripheral neuropathy CMT2A results from loss-of-function mutations disrupting MFN2's fusion capacity, leading to progressive axonal degeneration in long-distance sensory and motor neurons. These neurons are particularly vulnerable due to high bioenergetic demands and reliance on efficient mitochondrial transport and networking. M
Pathway Diagram
The following diagram shows the key molecular relationships involving Mitofusin 2 (MFN2) discovered through SciDEX knowledge graph analysis: